Jody Stark, NP

NPI: 1851472989
Total Payments
$591.32
2024 Payments
$31.41
Companies
17
Transactions
35
Medicare Patients
3,924
Medicare Billing
$270,983

Payment Breakdown by Category

Food & Beverage$591.32 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $591.32 35 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $128.90 8 $0 (2022)
E.R. Squibb & Sons, L.L.C. $120.00 4 $0 (2022)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $52.25 4 $0 (2022)
Dexcom, Inc. $44.47 3 $0 (2024)
Abbott Laboratories $38.10 2 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $35.15 2 $0 (2021)
Bayer HealthCare Pharmaceuticals Inc. $25.17 2 $0 (2022)
Neurocrine Biosciences, Inc. $19.49 1 $0 (2023)
Otsuka America Pharmaceutical, Inc. $17.86 1 $0 (2023)
IDORSIA PHARMACEUTICALS US INC $17.28 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $31.41 2 Averitas Pharma Inc. ($16.15)
2023 $79.24 5 Neurocrine Biosciences, Inc. ($19.49)
2022 $289.86 15 E.R. Squibb & Sons, L.L.C. ($104.75)
2021 $190.81 13 AbbVie Inc. ($60.49)

All Payment Transactions

35 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/11/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $15.26 General
Category: Endocrinology
03/20/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $16.15 General
Category: PAIN MANAGEMENT
07/25/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $17.86 General
Category: PSYCHIATRY
06/22/2023 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $17.28 General
Category: INSOMNIA
05/30/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $19.49 General
Category: Neuropsychiatry
04/25/2023 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $7.58 General
Category: CNS Stimulant for ADHD
04/18/2023 Lilly USA, LLC MOUNJARO (Drug) Food and Beverage In-kind items and services $17.03 General
Category: Diabetes
11/10/2022 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $12.15 General
Category: Endocrinology
10/19/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $14.02 General
Category: NEUROSCIENCE
10/04/2022 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $17.06 General
Category: Endocrinology
08/31/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.00 General
Category: Gastroenterology
08/24/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $13.06 General
Category: Cardio-renal
06/08/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $17.07 General
Category: NEUROSCIENCE
05/18/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $12.11 General
Category: Cardio-renal
05/11/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $13.73 General
Category: Gastroenterology
03/29/2022 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $56.32 General
Category: Cardiovascular
03/24/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.69 General
Category: NEUROSCIENCE
03/23/2022 Boehringer Ingelheim Pharmaceuticals, Inc. STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT Food and Beverage In-kind items and services $16.14 General
Category: RESPIRATORY
03/09/2022 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $12.65 General
Category: Cardiovascular
03/01/2022 Abbott Laboratories FREESTYLE LIBRE 2 (Device) Food and Beverage In-kind items and services $19.45 General
Category: Diabetes Care
01/27/2022 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $35.78 General
Category: Cardiovascular
01/12/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $19.63 General
Category: NEUROSCIENCE
12/15/2021 AbbVie Inc. QULIPTA (Drug) Food and Beverage In-kind items and services $11.95 General
Category: NEUROSCIENCE
12/01/2021 Abbott Laboratories FreeStyle Libre 2 (Device) Food and Beverage In-kind items and services $18.65 General
Category: Diabetes Care
11/17/2021 AbbVie Inc. QULIPTA (Drug) Food and Beverage In-kind items and services $13.58 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 744 1,171 $160,758 $54,958
2022 13 928 1,452 $178,373 $59,718
2021 15 1,074 1,773 $213,734 $74,567
2020 19 1,178 2,240 $269,890 $81,740
Total Patients
3,924
Total Services
6,636
Medicare Billing
$270,983
Procedure Codes
56

All Medicare Procedures & Services

56 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 188 381 $56,769 $18,905 33.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 105 153 $31,212 $11,030 35.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 102 102 $26,010 $10,988 42.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 175 287 $31,570 $8,626 27.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 15 17 $4,624 $2,023 43.8%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 30 34 $4,985 $1,588 31.9%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 11 14 $2,808 $896.40 31.9%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 49 58 $2,030 $474.61 23.4%
81002 Urinalysis, manual test Office 2023 69 125 $750.00 $426.25 56.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 219 388 $57,812 $18,299 31.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 216 410 $45,100 $13,024 28.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 95 95 $24,225 $10,365 42.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 102 134 $27,336 $9,072 33.2%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 51 60 $8,400 $2,654 31.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 15 18 $4,896 $2,159 44.1%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 15 15 $4,575 $2,088 45.6%
81002 Urinalysis, manual test Office 2022 109 199 $1,194 $671.83 56.3%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2022 15 30 $840.00 $489.90 58.3%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 45 53 $1,855 $376.76 20.3%
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) Office 2022 15 17 $391.00 $277.71 71.0%
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional Office 2022 17 19 $1,539 $180.54 11.7%
82270 Stool analysis for blood to screen for colon tumors Office 2022 14 14 $210.00 $60.25 28.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 256 493 $73,457 $24,843 33.8%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 208 395 $43,450 $12,887 29.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 133 169 $34,476 $12,159 35.3%

About Jody Stark, NP

Jody Stark, NP is a Psychiatric/Mental Health healthcare provider based in Ontario, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851472989.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jody Stark, NP has received a total of $591.32 in payments from pharmaceutical and medical device companies, with $31.41 received in 2024. These payments were reported across 35 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($591.32).

As a Medicare-enrolled provider, Stark has provided services to 3,924 Medicare beneficiaries, totaling 6,636 services with total Medicare billing of $270,983. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.

Practice Information

  • Specialty Psychiatric/Mental Health
  • Other Specialties Family
  • Location Ontario, OR
  • Active Since 10/17/2006
  • Last Updated 10/19/2022
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • NPI Number 1851472989

Products in Payments

  • ELIQUIS (Drug) $120.00
  • UBRELVY (Drug) $74.46
  • XIFAXAN (Drug) $52.25
  • Dexcom G6 Transmitter (Medical Supply) $44.47
  • QULIPTA (Drug) $36.75
  • Kerendia (Drug) $25.17
  • ARALAST (Biological) $22.10
  • INGREZZA (Drug) $19.49
  • FREESTYLE LIBRE 2 (Device) $19.45
  • FreeStyle Libre 2 (Device) $18.65
  • REXULTI (Drug) $17.86
  • VRAYLAR (Drug) $17.69
  • QUVIVIQ (Drug) $17.28
  • MOUNJARO (Drug) $17.03
  • QUTENZA (Drug) $16.15
  • STIOLTO RESPIMAT (Drug) $16.14
  • GLASSIA (Biological) $13.05
  • BELBUCA (Drug) $12.96
  • LATUDA (Drug) $11.63
  • SOLIQUA 100/33 (Biological) $11.16

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Ontario